We identified an AP-1 dependent ATAC peak in resistant BCC cells within the first intron, which is closed in SMOi-sensitive BCCs27, and showed that Smad3 binding within the ATAC peak disappears with AP-1 inhibition (Fig. 6d). Here, JUN is linked to skin basal cell carcinoma.